Quarterly report pursuant to Section 13 or 15(d)

ACQUISITION (Details Narrative)

v3.8.0.1
ACQUISITION (Details Narrative) - Lewis & Clark Pharmaceuticals, Inc. [Member] - USD ($)
$ in Thousands
9 Months Ended
Jul. 31, 2017
Sep. 30, 2017
Percentage of ownership acquired 100.00%  
Share Exchange Agreement [Member]    
Percentage of ownership acquired 100.00%  
Number of shars issued upon acquistion (Purchase consideration) 7,122,172  
Number of shares issued upon acquistion, value (Purchase consideration) $ 2,492,760  
Number of shares received by shareholders (5% of the payment shares) 356,109  
Value of revenue and loss   $ 0
Value of revenue and loss   $ (149,000)
Escrow Agreement [Member]    
Number of shares held in escrow account $ 973,251